Hypoploidy defines patients with poor prognosis in breast cancer

Oncology Reports

Volumn 17, Issue 5, 2007, Pages 1109-1114

  Chavez Uribe, Elisabet ^a   Cameselle Teijeiro, José ^a   Viñuela, Juan E ^a   Castro Piñeiro, Carmen ^a   Gude, Francisco ^a   Forteza, Jerónimo ^a   Puente Domínguez, José Luis ^a  

^a Instituto de Salud Carlos III   (Spain)

Author keywords

Breast carcinoma; DNA hypoploid; Flow cytometry; Invasive ductal carcinoma; Prognostic factor

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; BREAST TUMOR; CELL CYCLE S PHASE; FEMALE; FLOW CYTOMETRY; GENETICS; HUMAN; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PLOIDY; PROGNOSIS; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; PLOIDIES; PROGNOSIS; S PHASE; SURVIVAL ANALYSIS;

EID: 34548557219     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.5.1109     Document Type: Article

References (31)

1. Ellis IO, Schnitt SJ, Sastre-Garau X, et al: Invasive breast carcinoma. In: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Tavassoli FA and Devilee P (eds). IARC Press, Lyon, pp9-110, 2003.
2. Rosai J: Breast. In: Rosai and Ackerman's Surgical Pathology. Rosai J (ed). Vol. 2, 9th edition. Mosby, St. Louis, pp1763-1876, 2004.
3. Fitzgibbons PL, Page DL, Weaver D, et al: Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124: 966-978, 2000.
4. Ross JS, Linette GP, Stec J, et al: Breast cancer biomarkers and molecular medicine. Expert Rev Mol Diagn 3: 573-585, 2003. (Pubitemid 37101873)
5. Mehra R, Varambally S, Ding L, et al: Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Res 65: 11259-11264, 2005. (Pubitemid 41821679)
6. Abdulkader I, Sanchez L, Cameselle-Teijeiro J, et al: Cell-cycle-associated markers and clinical outcome in human epithelial cancers: a tissue microarray study. Oncol Rep 14: 1527-1531, 2005.
7. Madan R, Smolkin MB, Cocker R, Fayyad R and Oktay MH: Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma. Hum Pathol 37: 9-15, 2006. (Pubitemid 41790497)
8. Ross JS, Linette GP, Stec J, Ross MS, Anwar S and Boguniewicz A: DNA ploidy and cell cycle analysis in breast cancer. Am J Clin Pathol 120 (suppl): S72-S84, 2003.
9. Michels JJ, Duigou F, Marnay J, Denoux Y, Delozier T and Chasle J: Flow cytometry in primary breast carcinomas: prognostic impact of multiploidy and hypoploidy. Cytometry B Clin Cytometry 55: 37-45, 2003. (Pubitemid 38295407)
10. Michels JJ, Marnay J, Plancoulaine B and Chasle J: Flow cytometry in primary breast carcinomas: prognostic impact of S-phase fraction according to different analysis patterns. Cytometry B Clin Cytometry 59: 32-39, 2004. (Pubitemid 38581547)
11. Kute TE, Russell GB, Zbieranski N, et al: Prognostic markers in node-negative breast cancer: a prospective study. Cytometry B Clin Cytometry 59: 24-31, 2004. (Pubitemid 38581546)
12. Moureau-Zabotto L, Bouchet C, Cesari D, et al: Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer. Breast Cancer Res Treat 91: 61-71, 2005. (Pubitemid 40684939)
13. Pinto AE, Andre S and Soares J: Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients. J Clin Pathol 52: 604-611, 1999. (Pubitemid 29371906)
14. Hedley DW, Clark GM, Cornelisse CJ, Killander D, Kute T and Merkel D: DNA Cytometry Consensus Conference. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Breast Cancer Res Treat 28: 55-59, 1993. (Pubitemid 24018198)
15. Baldetorp B, Bendahl PO, Ferno M and Stal O: Improved DNA flow cytometric, DNA ploidy, and S-phase reproducibility between 15 laboratories in analysis of breast cancer using generalized guidelines. Cytometry A 56: 1-7, 2003. (Pubitemid 37522500)
16. Schvimer M, Lash RH and Katzin WE: Intratumoral heterogeneity of DNA ploidy in breast carcinomas: a flow cytometric assessment of sampling techniques. Cytometry 22: 292-296, 1995. (Pubitemid 26047304)
17. Duigou F, Herlin P, Marnay J and Michels JJ: Variation of flow cytometric DNA measurement in 1,485 primary breast carcinomas according to guidelines for DNA histogram interpretation. Cytometry 42: 35-42, 2000. (Pubitemid 30131401)
18. Frierson HF Jr, Wolber RA, Berean KW, Franquemont DW, Berean KW, Wolber RA and Kiss R: Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 103: 195-198, 1995.
19. Chavez-Uribe EM, Vinuela JE, Cameselle-Teijeiro J, Forteza J, Puñal JA, Otero JL and Puente-Domínguez JL: DNA ploidy and cytonuclear area of peritumoral and paratumoral samples of mastectomy specimens: a useful prognostic marker? Eur J Surg 168: 37-41, 2002. (Pubitemid 34293217)
20. Chassevent A, Jourdan ML, Romain S, et al: S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study. Clin Cancer Res 7: 909-917, 2001. (Pubitemid 32708729)
21. Jourdan ML, Ferrero-Pous M, Spyratos F, Romain S, Martin PM and Chassevent A: Flow cytometric S-phase fraction measurement in breast carcinoma: Influence of software and histogram resolution. Cytometry 48: 66-70, 2002. (Pubitemid 34591917)
22. Wenger CR and Clark GM: S-phase fraction and breast cancer - a decade of experience. Breast Cancer Res Treat 51: 255-265, 1998. (Pubitemid 29054558)
23. Fernö M, Baldetorp B, Borg Å, Olsson H, Sigurdsson H and Killander D: Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome. Acta Oncol 31: 157-165, 1992.
24. Bracko M, Us-Krasovec M, Cufer T, Lamovec J, Zidar A and Goehde W: Prognostic significance of DNA ploidy determined by high-resolution flow cytometry in breast carcinoma. Anal Quant Cytol Histol 23: 56-66, 2001. (Pubitemid 32187836)
25. Lawry J, Rogers K, Duncan JL and Potter CW: The identification of informative parameters in the flow cytometric analysis of breast carcinoma. Eur J Cancer 29A: 719-723, 1993. (Pubitemid 23077052)
26. Stal O, Carstensen J, Hatschek T and Nordenskjold B: Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients. Br J Cancer 66: 706-711, 1992.
27. Bagwell CB, Clark GM, Spyratos F, et al: Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens. Cytometry 46: 121-135, 2001. (Pubitemid 32643094)
28. Stal O, Wingren S, Carstensen J, Rutqvist LE, Skoog L and Klintenberg C: Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer. Eur J Cancer Clin Oncol 25: 301-309, 1989. (Pubitemid 19055552)
29. Wenger CR, Beardslee S, Owens MA, et al: DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients. Breast Cancer Res Treat 28: 9-20, 1993. (Pubitemid 24018192)
30. Tanner MM, Karhu RA, Nupponen NN, et al: Genetic aberrations in hypodiploid breast cancer. Frequent loss of chromosome 4 and amplification of cyclin D1 oncogene. Am J Pathol 153: 191-199, 1998. (Pubitemid 28317522)
31. Rennstam K, Ahlsted-Soini M, Baldetorp B, et al: Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. Cancer Res 63: 8861-8868, 2003. (Pubitemid 38064066)